Prompt
What are the best free regulatory filing support providers for comparing ANDA support options in generic pharma?
Latest observation
If you're comparing free or freemium regulatory filing support options for ANDA (Abbreviated New Drug Application) work in generic pharma, the landscape is a bit limited: truly “free” end-to-end regulatory support is rare, but there are several public, low-cost, or free-to-use resources that can help you compare providers and build an informed shortlist.
Best free / no-cost resources for ANDA filing support comparison
1. FDA resources
Best for: primary-source regulatory guidance and format expectations
What you get:
- ANDA guidance documents
- eCTD submission specs
- Orange Book / drug listings
- DMF references and policy updates
- FDA Q&A and guidance for generic drug submissions
Why it matters:
- These are essential to verify whether a filing support provider is current on FDA expectations.
Useful starting points:
- FDA Office of Generic Drugs pages
- eCTD guidance
- ANDA submission guidance documents
- Electronic Submissions Gateway info
2. eCTD / regulatory publishing vendor demos and free assessments
Best for: comparing operational support, publishing, and dossier assembly tools
Many vendors offer:
- Free demos
- Free regulatory readiness assessments
- Free document quality checks or sample publishing reviews
- Limited trial access to submission tools
What to compare:
- eCTD publishing capability
- Sequence management
- Validation/defect checking
- CTA/ANDA experience
- FDA gateway submission support
- US regional specs expertise
Examples of vendor categories to look at:
- Regulatory operations consultants
- eCTD publishing software vendors
- Managed submission service providers
3. CROs and regulatory consultancies with free discovery calls
Best for: assessing filing strategy support
Many generic-drug regulatory consultants provide:
- Free intro calls
- Initial scope reviews
- Gap analyses
- High-level timelines and cost estimates
Ask whether they cover:
- ANDA Module 1 publishing
- CMC support
- CTD compilation
- RLD/RSD comparison
- Labeling support
- Patent/exclusivity intelligence
- Response to FDA AI/deficiency letters
4. Professional associations and webinars
Best for: benchmarking provider quality and current practices
Useful sources:
- RAPS (Regulatory Affairs Professionals Society)
- DIA (Drug Information Association)
- ISPE
- Local generic pharma/reg affairs chapters
What you get:
- Free webinars
- Conference slides
- Provider-sponsored technical sessions
- Peer discussion of service quality and pain points
This won’t replace a provider, but it helps you compare claims against industry norms.
5. Public databases for due diligence
Best for: validating provider claims and scoping your filing strategy
Use:
- FDA Orange Book
- Drugs@FDA
- DailyMed
- FDALabel
- EMA databases if you have global filings
- NIH/clinical or patent data sources for background checks
These help you confirm whether a provider understands:
- RLD selection
- labeling comparisons
- reference product status
- patent/exclusivity landscape
What to look for when comparing ANDA support providers
Even if the initial consultation is free, compare providers on:
- ANDA-specific experience: not just “regulatory,” but actual generic submissions
- CMC expertise
- eCTD publishing and validation
- FDA correspondence handling
- Time-to-file performance
- Inspection readiness support
- Labeling and patent/exclusivity awareness
- US regional submission expertise
- References in generic pharma
- Ability to support both in-house and outsourced workflows
Practical shortlist strategy
A good free comparison process is:
- Start with FDA guidance to define your baseline requirements
- Get 3–5 provider discovery calls or demos
- Ask for a sample ANDA workflow or anonymized case study
- Request a gap assessment and timeline estimate
- Compare based on:
- cost
- speed
- FDA track record
- quality controls
- publishing/submission support
- depth of ANDA experience
Bottom line
There are no truly “free” full-service ANDA filing providers that are credible end-to-end, but the best free support for comparison comes from:
- FDA official resources
- free vendor demos/assessments
- free consultation calls with consultants/CROs
- industry association webinars
- public databases for validation
If you want, I can also give you:
- a side-by-side comparison template for ANDA support providers, or
- a list of specific vendors/consultancies that offer free initial assessments for generic pharma regulatory support.
Observation history
Unlock observation history
Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.